The leukotriene D4-receptor antagonist zafirlukast attenuates exercise- induced bronchoconstriction in children

Journal of Pediatrics

Volumn 134, Issue 3, 1999, Pages 273-279

  Pearlman, David S ^a,b,c,d   Ostrom, Nancy K ^a,b,c,d   Bronsky, Edwin A ^a,b,c,d   Bonuccelli, Catherine M ^a,b,c,d   Hanby, Laura A ^a,b,c,d  

^a Respiratory Institute   (United States)

^b ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^c Intermountain Clinical Research   (United States)

^d ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; ZAFIRLUKAST; ANTIASTHMATIC AGENT; TOLUENESULFONIC ACID DERIVATIVE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EXERCISE INDUCED ASTHMA; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PHARYNGITIS; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; VERTIGO; ANALYSIS OF VARIANCE; BRONCHOSPASM; DOSE RESPONSE; EXERCISE TEST; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; SPIROMETRY; STATISTICS; TIME;

ADMINISTRATION, ORAL; ADOLESCENT; ANALYSIS OF VARIANCE; ANTI-ASTHMATIC AGENTS; ASTHMA, EXERCISE-INDUCED; BRONCHOCONSTRICTION; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXERCISE TEST; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; SPIROMETRY; TIME FACTORS; TOSYL COMPOUNDS;

EID: 0033238050     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70449-X     Document Type: Article

References (29)

1. 1. Vital and health statistics: current estimates from the national health interview survey, 1994. Hyattsville (MD): National Center for Health Statistics; 1995:82. US Department of Health and Human Services Publication No. (PHS) 96-1521. Series 10, no. 193.
2. 2. McFadden ER Jr, Gilbert IA. Exercise-induced asthma. N Engl J Med 1994;330:1362-7.
3. 3. Joseph CLM, Foxman B, Leickly FE, Peterson E, Ownby D. Prevalence of possible undiagnosed asthma and associated morbidity among urban school-children. J Pediatr 1996;129:735-42.
4. 4. Anderson SD. Exercise-induced asthma. In: Middleton E, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy: principles and practice. 4th ed. St Louis: Mosby; 1993. p. 1343-67.
5. 5. Freed AN. Models and mechanisms of exercise-induced asthma. Eur Respir J 1995;8:1770-85.
6. 6. Bjornsdottir US, Bush RK. Leukotriene antagonists and inhibitors. Immunol Allergy Clin N A 1993;13:861-90.
7. 4 receptor antagonist. Am Rev Respir Dis 1992;145:746-9.
8. 4-receptor antagonist. N Engl J Med 1990;323:1736-39.
9. 9. Robuschi M, Riva E, Fuccella LM, Vida E, Barnabe R, Rossi M, et al. Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). Am Rev Respir Dis 1992;146:1285-8.
10. 10. Bronsky EA, Kemp JP, Zhang J, Guerreiro D, Reiss TF. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval. Clin Pharmacol Ther 1997;62:556-61.
11. 11. Meltzer SS, Hasday JF, Cohn J, Bleecker ER. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor. Am J Respir Crit Care Med 1996;153:931-5.
12. 12. Eggleston PA, Guerrant JL. A standardized method of evaluating exercise-induced asthma. J Allergy Clin Immunol 1976;58:414-25.
13. 13. American Thoracic Society Committee on Diagnostic Standards. Definitions and classifications of chronic bronchitis, asthma, and pulmonary emphysema. Am Rev Respir Dis 1962;85:762-8.
14. 14. Senn S. Cross-over Trials in Clinical Research. New York: John Wiley & Sons; 1993.
15. 15. Agresti A. Categorical Data Analysis. New York: John Wiley & Sons; 1990.
16. 16. Kawabori I, Pierson WE, Conquest LL, Bierman CW. Incidence of exercise-induced asthma in children. J Allergy Clin Immunol 1976;58:447-55.
17. 17. Godfrey S, Bar-Yishay E. Exercise-induced asthma revisited. Respir Med 1993;87:331-44.
18. 18. de Benedictis FM, Tuteri G, Bertotto A, Bruni L, Vaccaro R. Comparison of the protective effects of cromolyn sodium and nedocromil sodium in the treatment of exercise-induced asthma in children. J Allergy Clin Immunol 1994;94:684-8.
19. 19. Silverman M, Anderson SD. Standardization of exercise tests in asthmatic children. Arch Dis Child 1972;47:882-9.
20. 20. Johnson JD. Statistical considerations in studies of exercise-induced bronchospasm. J Allergy Clin Immunol 1996;64:634-41.
21. 21. Bronsky EA, Spector SL, Pearlman DS, Justus SE, Bishop AL. Albuterol aerosol versus albuterol Rotacaps in exercise-induced bronchospasm in children. J Asthma 1995;32:207-14.
22. 22. Godfrey S, Silverman M. Demonstration by placebo response in asthma by means of exercise testing. J Psychosom Res 1973;17:293-7.
23. 23. National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. Washington, DC: National Institutes of Health; 1997. US Dept of Health and Human Services Publication NIH 97-4051. p. 100.
24. 2-agonists. In: Weiler JM, editor. Allergic and respiratory disease - sports medicine. New York: Marcel Dekker; 1997. p. 159-77.
25. 2-agonists. In: Weiler JM, editor. Allergic and respiratory disease - sports medicine. New York: Marcel Dekker; 1997. p. 141-58.
26. 26. Anderson S, Seale JP, Ferris L, Schoeffel R, Lindsay DA. An evaluation of pharmacotherapy for exercise-induced asthma. J Allergy Clin Immunol 1979;64:612-24.
27. 27. Ellis EF. Inhibition of exercise-induced asthma by theophylline. J Allergy Clin Immunol 1984;73:690-2.
28. 28. de Benedictis FM, Tuteri G, Pazzelli P, Bertotto A, Bruni L, Vaccaro R. Cromolyn versus nedocromil: duration of action in exercise-induced asthma in children. J Allergy Clin Immunol 1995;96:510-4.
29. 29. Woolley M, Anderson SD, Quigley BM. Duration of protective effect of terbutaline sulfate and cromolyn sodium alone and in combination on exercise-induced asthma. Chest 1990;97:39-45.